Atlantic Health System Enrolls First U.S. Patient in Lupus Treatment Trial
NJ-based Atlantic Health System is the first in the U.S. to enroll a patient in a study to examine the effectiveness of using Chimeric Antigen Receptor (CAR- T) cells in the treatment of the autoimmune disease lupus.
8-Feb-2024 8:50 AM EST
Add to Favorites